CV Lattes
ORCID
Abstract
Human serum albumin nanoparticles (HSA-PNPs) have emerged as promising carriers for small interfering RNAs (siRNAs) in cancer therapy. However, challenges such as efficient cellular internalization and endosomal escape of encapsulated siRNAs remain poorly addressed. This project proposes the development of HSA-PNPs responsive to biological stimuli, such as pH and glutathione concentration…